Diligence memo · auto-generated · as of July 2, 2026
BluDiagnostics, Inc.
BluDiagnostics, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
BluDiagnostics, Inc. operates in Biotechnology, based in MADISON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BluDiagnostics, Inc. has raised $4.5M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.4M on 2018-05-15.
Most recent recorded round closed around 2018-05-15.
Valuation (modeled)modeled
Provath models BluDiagnostics, Inc. at approximately $151M (range $2.4M–$1.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.12× the median modeled value of Seed Biotechnology companies in 2016–2018 (175 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 8.1 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 5.7× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 42% of Biotechnology peers (4293 compared).
Modeled value ranks above 66% of those peers.
Closest niche peers: Mimedx Group, Inc., Kenjockety Biotechnology, LLC, Helocyte, Inc., CytoDel, INC., Finch Therapeutics, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.